Gufic Biosciences Ltd
As of 20 Nov 2026, Gufic Biosciences is in Stage 2, the uptrend phase, now in week 20 (since 1 Jul 2026). It closed at ₹418, 14.1% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. More about the company
Pro read
ProGUFICBIO is about 5 months into its Stage 2 advance, 2% below its 50-day average and 14% under its 52-week high. A pause below the 50-day inside an uptrend is the weakest spot of the move until it closes back above the line.
Its relative strength is 84 of 99, a leader among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.
Stocks with a similar setup ran 0.1 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 17% above entry.
The trend read holds while it stays in Stage 2. A close below ₹426, its 50-day average, would put it at rest; ₹390, 20% under its 52-week high of ₹487, is where a trailing stop would sit.
Setup-score rank among Stage 2 peers: #19 of 50 in Pharmaceuticals · #24 of 61 in Health Care
Is GUFICBIO early, or has it already run? Pro answers that for every NSE stock, after every close.
GUFICBIO among Pharmaceuticals40th of 118 by relative strength
All 118 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BLISSGVS | Stage 2 · wk 49 | 99 | +4.6% |
| 2 | KPL | Stage 2 · wk 44 | 99 | +20.5% |
| 3 | FREDUN | Stage 2 · wk 33 | 98 | +24.0% |
| 4 | VENUSREM | Stage 3 · wk 10 | 98 | −1.5% |
| 5 | RUBICON | Stage 3 · wk 4 | 98 | +18.7% |
| 6 | SAKAR | Stage 2 · wk 55 | 98 | +13.1% |
| 7 | BAFNAPH | Stage 2 · wk 23 | 98 | +1.9% |
| 8 | INDSWFTLAB | Stage 2 · wk 23 | 98 | −7.4% |
| …40 | GUFICBIO | Stage 2 · wk 20 | 84 | +7.4% |
Mutual fund holdings
Held by 11 mutual funds in portfolios to October 2026: 7 active funds and 4 index funds and ETFs.
In October, among active funds: 1 increased and 1 reduced.
All 11 funds and what each did in October
Mutual funds holding GUFICBIO: the ten largest and the month’s moves →
Gufic Biosciences: quick answers
What stage is Gufic Biosciences in?
As of 20 Nov 2026, Gufic Biosciences (GUFICBIO) is in Stage 2, the uptrend phase. It entered Stage 2 on 1 Jul 2026 and is in week 20. What the four stages mean
Is Gufic Biosciences in an uptrend?
Yes. Gufic Biosciences is in a Stage 2 uptrend. It trades 15.6% above its 200-day average, which is rising.
How far is Gufic Biosciences from its 52-week high?
Gufic Biosciences closed at ₹418 on 20 Nov 2026, 14.1% below its 52-week high of ₹487. Its 52-week low is ₹274.
How has Gufic Biosciences performed over the past year?
As of 20 Nov 2026, Gufic Biosciences is up 28.9% over the past year and up 24.5% so far in 2026.
Which sector and industry is Gufic Biosciences in?
Gufic Biosciences is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals
About this companyHealth Care· Pharmaceuticals
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, and South America. The company manufactures APIs and bulk drugs, such as antifungals, anaethetics, immuno suppressants, anginotensin receptor blocker, and intermediates for antifungals. It also manufactures lyophilized injections for antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. Further, it engages in contract and bulk drug manufacturing business. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.